InvestorsHub Logo
Followers 5
Posts 508
Boards Moderated 0
Alias Born 03/31/2014

Re: HennHouse post# 21359

Friday, 11/07/2014 6:12:40 PM

Friday, November 07, 2014 6:12:40 PM

Post# of 32851
Entire PR on lawsuit:

Vancouver, BC / ACCESSWIRE / November 7, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQX: ATTBF) (CSE: ATT), wishes to advise its shareholders that the U.S. Federal Court in Washington State has this morning declined to exercise federal jurisdiction over the Company's recently announced claims. As a preliminary jurisdictional matter, the court indicated that it did not believe it was an appropriate venue for legal proceedings relating to the state's Marijuana industry. While the Court stated that the Company had fought "valiantly" during the hearing in advocating for federal jurisdiction, it also made plain that, unlike other jurisdictions throughout the U.S. which had exercised jurisdiction, it was bound by a prior legal decision from the ninth circuit that narrowed the ability of the Court to exercise federal jurisdiction in a similar case. The Court took the extraordinary step, however, of warning the defendants that it's decision to decline exercising federal jurisdiction should not be considered "a win" as the Company was likely to refile it's allegations in Washington state court. As predicted in the ruling, the Company is in preparations to immediately refile its complaint and seek a temporary restraining order on an emergency basis in Washington state court. Unlike the federal system, Washington state courts generally align more closely with state law on claims based on disputes within the Marijuana industry. The